Monthly Archives: September 2009

FDLI Conference – Part 2 – Janet Woodcock Speech

Posted on September 21, 2009 by Mark Senak

At the opening of the 20th Food and Drug Law Institute Conference Annual Advertising and Promotion Conference, CDER's Dr. Janet Woodcock stood in for Dr. Margaret Hamburg who was said to have had a scheduling conflict due to a meeting … Continue reading →

Posted in DTC Advertising, FDA Policy | Comments Off on FDLI Conference – Part 2 – Janet Woodcock Speech

FDLI Conference Part 1

Posted on September 20, 2009 by Mark Senak

Well it is an interesting turn of events.  The Food and Drug Law Institute is holding a large conference here in Washington on September 21- 22.  Heading up the list of speakers was billed to be Dr. Margaret Hamburg, the … Continue reading →

Posted in FDA Policy | Comments Off on FDLI Conference Part 1

FDA to Hold Part 15 Hearing on Social Media and Pharma – Finally!

Posted on September 18, 2009 by Mark Senak

This is nothing less than astounding.  The FDA is seeking input on social media and pharma. The hearing will be held on November 12 and 13 in Washington DC.  Details are here.    I have often railed against the DDMAC … Continue reading →

Posted in FDA Policy, New and Social Media | 1 Comment

Weekly Roundup – 9-18-09

Posted on September 18, 2009 by Mark Senak

Well, now that the summer is over and Congress is back from their "recess" I decided it was time to bring back the Weekly Roundup as there is more happening in DC than usual and I'm more back in the … Continue reading →

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 9-18-09

Update on FDA Transparency

Posted on September 17, 2009 by Mark Senak

Back in July, in response to the formation of the FDA's Transparency Task Force, I wrote a posting called "When Transparency is Easy – Advisory Committee Transparency".  The point made was that while it used to be quite easy to … Continue reading →

Posted in FDA Image | Comments Off on Update on FDA Transparency